glp 1 gout SGLT2 Inhibitors, but Not GLP-1 Receptor Agonists, Reduce Incidence of in People Living With Type 2 Diabetes Across the Therapeutic Spectrum GLP-1 drugs linked to osteoporosis
Description
Sodium polystyrene sulfonate is an older binder with limited supportive evidence [88]
The timing is the strongest clue
The full range of BMIs in both groups ran from "healthy" to "severely obese ," with similar proportions of people in each category in each group
Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, et al
Other information lacking in some studies was the identification of diabetic complications (retinopathy, nephropathy, neuropathy), which could have affected the choice of insulin or fracture risk
